| DRUG WATCH |
|
| Year : 2020 | Volume
: 52
| Issue : 2 | Page : 138-141 |
Potentially blinding adverse drug reaction to peribulbar lignocaine anesthesia: A rare case report
Saurabh Deshmukh, Harsha Bhattacharjee, Krati Gupta
Department of Vitreo-Retina Services, Sri Sankaradeva Nethralaya, Guwahati, Assam, India
Correspondence Address:
Saurabh Deshmukh
Department of Vitreo-Retina Services, Sri Sankaradeva Nethralaya, 96, Beltola, Guwahati - 781 028, Assam
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_4_19
Peribulbar lignocaine anesthesia is commonly used in ophthalmic surgeries. It rarely causes any severe allergic reaction. A 63-year-old male presented with complicated pseudophakia. He underwent successful vitrectomy under local anesthesia. He later presented with acute-onset proptosis, orbital swelling, and extraocular movement restriction. He was afebrile with normal blood workup and radiological investigations and gave a similar past history. The patient was treated successfully with intravenous medications but two months later developed optic atrophy. An adverse reaction to lignocaine appears to be the most probable cause. Early detection and prompt management of this condition may avert a potentially grave visual outcome. Literature review shows that this case is one of its kinds to report this potentially blinding complication of peribulbar lignocaine anesthesia.
[FULL TEXT] [PDF]*
|
